Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals
Authors
Keywords
-
Journal
Frontiers in Psychology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-10-05
DOI
10.3389/fpsyg.2022.948729
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brain serotonin transporter is associated with cognitive‐affective biases in healthy individuals
- (2022) Sophia Armand et al. HUMAN BRAIN MAPPING
- Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report
- (2022) Drummond E-Wen McCulloch et al. Frontiers in Pharmacology
- Psychedelic Experiences and Mindfulness are Associated with Improved Wellbeing
- (2022) Tianhong Tim Qiu et al. JOURNAL OF PSYCHOACTIVE DRUGS
- Trial of Psilocybin versus Escitalopram for Depression
- (2021) Robin Carhart-Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience
- (2021) Martin K. Madsen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Blinding and expectancy confounds in psychedelic randomized controlled trials
- (2021) Suresh D. Muthukumaraswamy et al. Expert Review of Clinical Pharmacology
- Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy
- (2021) Maria Eleni Eleftheriou et al. Frontiers in Psychiatry
- A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding
- (2020) Martin Korsbak Madsen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review
- (2020) Kristin Heuschkel et al. Frontiers in Psychiatry
- Common HTR2A variants and 5‐HTTLPR are not associated with human in vivo serotonin 2A receptor levels
- (2020) Marie Spies et al. HUMAN BRAIN MAPPING
- Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans
- (2020) Dea Siggaard Stenbæk et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies
- (2020) Kristoffer A. A. Andersen et al. ACTA PSYCHIATRICA SCANDINAVICA
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
- (2019) Martin K. Madsen et al. NEUROPSYCHOPHARMACOLOGY
- Cessation and reduction in alcohol consumption and misuse after psychedelic use
- (2019) Albert Garcia-Romeu et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms
- (2019) M. V. Uthaug et al. PSYCHOPHARMACOLOGY
- Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects
- (2019) Lukasz Smigielski et al. NEUROIMAGE
- Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat
- (2019) Lukasz Smigielski et al. Scientific Reports
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
- (2018) Leor Roseman et al. Frontiers in Pharmacology
- Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution
- (2018) M. V. Uthaug et al. PSYCHOPHARMACOLOGY
- Looking for the Self: Phenomenology, Neurophysiology and Philosophical Significance of Drug-induced Ego Dissolution
- (2017) Raphaël Millière Frontiers in Human Neuroscience
- Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors
- (2017) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
- (2017) Robin L Carhart-Harris et al. NEUROPSYCHOPHARMACOLOGY
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
- (2017) R. L. Carhart-Harris et al. PSYCHOPHARMACOLOGY
- Cerebral 5-HT release correlates with [11C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain
- (2016) Louise M Jørgensen et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System
- (2016) Vincent Beliveau et al. JOURNAL OF NEUROSCIENCE
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Serotonin 2A receptor agonist binding in the human brain with [ 11 C]Cimbi-36: Test–retest reproducibility and head-to-head comparison with the antagonist [ 18 F]altanserin
- (2016) Anders Ettrup et al. NEUROIMAGE
- Functional neuroanatomy of meditation: A review and meta-analysis of 78 functional neuroimaging investigations
- (2016) Kieran C.R. Fox et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Long-term follow-up of psilocybin-facilitated smoking cessation
- (2016) Matthew W. Johnson et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
- (2015) Frederick S Barrett et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
- (2015) Michael P Bogenschutz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Association between Mindfulness and Weight Status in a General Population from the NutriNet-Santé Study
- (2015) Géraldine M. Camilleri et al. PLoS One
- Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities
- (2015) Joaquim Soler et al. PSYCHOPHARMACOLOGY
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
- (2014) Robin L. Carhart-Harris et al. Frontiers in Human Neuroscience
- Serotonin 2A Receptor Agonist Binding in the Human Brain with [11C]Cimbi-36
- (2014) Anders Ettrup et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
- (2014) Matthew W Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Characterization of [11C]Cimbi-36 as an agonist PET radioligand for the 5-HT2A and 5-HT2C receptors in the nonhuman primate brain
- (2013) Sjoerd J. Finnema et al. NEUROIMAGE
- Prediction of Psilocybin Response in Healthy Volunteers
- (2012) Erich Studerus et al. PLoS One
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
- (2012) R. L. Carhart-Harris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
- (2011) Katherine A MacLean et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Meditation experience is associated with differences in default mode network activity and connectivity
- (2011) J. A. Brewer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
- (2011) Roland R. Griffiths et al. PSYCHOPHARMACOLOGY
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
- A Nonlinear Relationship between Cerebral Serotonin Transporter and 5-HT2A Receptor Binding: An In Vivo Molecular Imaging Study in Humans
- (2010) D. Erritzoe et al. JOURNAL OF NEUROSCIENCE
- Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group- and isolation-housed mice
- (2008) Lydia Günther et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
- (2008) RR Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Frontolimbic Serotonin 2A Receptor Binding in Healthy Subjects Is Associated with Personality Risk Factors for Affective Disorder
- (2007) Vibe G. Frokjaer et al. BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search